Mendel Castle‐Kirszbaum
-
- Pituitary Gland Disorders and Treatments 20
-
- Glioma Diagnosis and Treatment 4
- Otorhinolaryngology top 10%
- Sinusitis and nasal conditions 5
-
- Traumatic Brain Injury and Neurovascular Disturbances 6
-
- Head and Neck Surgical Oncology 12
-
- Meningioma and schwannoma management 10
-
- Cerebrospinal fluid and hydrocephalus 8
-
- Spine and Intervertebral Disc Pathology 6
Mendel Castle‐Kirszbaum
39 papers receiving 339 citations
Peers
Comparison fields: 5 of 53
- Endocrinology, Diabetes and Metabolism 208
- Genetics 66
- Otorhinolaryngology 27
- Neurology 67
- Surgery 129
Countries citing papers authored by Mendel Castle‐Kirszbaum
This map shows the geographic impact of Mendel Castle‐Kirszbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mendel Castle‐Kirszbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mendel Castle‐Kirszbaum more than expected).
Fields of papers citing papers by Mendel Castle‐Kirszbaum
This network shows the impact of papers produced by Mendel Castle‐Kirszbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mendel Castle‐Kirszbaum. The network helps show where Mendel Castle‐Kirszbaum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mendel Castle‐Kirszbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 21 | |
| 16 | 2021 | 16 | |
| 17 | 2021 | 14 | |
| 18 | 2021 | 19 | |
| 19 | 2021 | 6 | |
| 20 | 2020 | 8 |
About Mendel Castle‐Kirszbaum
Mendel Castle‐Kirszbaum is a scholar working on Endocrinology, Diabetes and Metabolism, Otorhinolaryngology and Neurology, having authored 45 papers that have together received 343 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (20 papers), Head and Neck Surgical Oncology (12 papers), Meningioma and schwannoma management (10 papers), Cerebrospinal fluid and hydrocephalus (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (6 papers), Spine and Intervertebral Disc Pathology (6 papers), Sinusitis and nasal conditions (5 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (208 citations), Genetics (66 citations) and Otorhinolaryngology (27 citations). Mendel Castle‐Kirszbaum has collaborated with scholars based in Australia, Canada and Netherlands. Frequent co-authors include Tony Goldschlager, James King, Yi Yuen Wang, Brent Uren, W. G. Parkin, R. Andrew Danks, Ronil V. Chandra, Peter J. Fuller, Julian Maingard and Christopher Wright. Their work appears in journals such as Journal of neurosurgery, Neurosurgery and American Journal of Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.